UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer

Nature communications, 2020-11, Vol.11 (1), p.5513-5513, Article 5513

2020

Volltextzugriff (PDF)

Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer

Nature communications, 2020-03, Vol.11 (1), p.1456-18, Article 1456

2020

Volltextzugriff (PDF)

Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells

Nature cell biology, 2019-04, Vol.21 (4), p.498-510

2019

Volltextzugriff (PDF)

Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression

Molecular cancer, 2020-03, Vol.19 (1), p.65-65, Article 65

2020

Volltextzugriff (PDF)

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

Nature communications, 2018-04, Vol.9 (1), p.1595-11, Article 1595

2018

Volltextzugriff (PDF)

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients

Nature communications, 2018-04, Vol.9 (1), p.1614-13, Article 1614

2018

Volltextzugriff (PDF)

Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy

Nature communications, 2020-11, Vol.11 (1), p.5842-13, Article 5842

2020

Volltextzugriff (PDF)

DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25

Nature (London), 2020-07, Vol.583 (7814), p.133-138

2020

Volltextzugriff (PDF)

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Nature communications, 2022-05, Vol.13 (1), p.3011-10, Article 3011

2022

Volltextzugriff (PDF)

Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer

Nature communications, 2022-11, Vol.13 (1), p.7160-19, Article 7160

2022

Volltextzugriff (PDF)

Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer

Nature immunology, 2021-07, Vol.22 (7), p.865-879

2021

Volltextzugriff (PDF)

circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer

Molecular cancer, 2022-01, Vol.21 (1), p.8-8, Article 8

2022

Volltextzugriff (PDF)

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

Journal for immunotherapy of cancer, 2020-05, Vol.8 (1), p.e000696

2020

Volltextzugriff (PDF)

NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death

Nature immunology, 2018-10, Vol.19 (10), p.1112-1125

2018

Volltextzugriff (PDF)

Targeting Stemness: Implications for Precision Medicine in Breast Cancer

Translational Research in Breast Cancer, 2017, Vol.1026, p.147-169

2017

Volltextzugriff (PDF)

The Role of APAL/ST8SIA6-AS1 lncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells

JNCI : Journal of the National Cancer Institute, 2020-04, Vol.112 (4), p.356-368

2020

Volltextzugriff (PDF)

The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)

The Journal of biological chemistry, 2013-04, Vol.288 (16), p.10973-10985

2013

Volltextzugriff (PDF)

LncRNA NRON promotes tumorigenesis by enhancing MDM2 activity toward tumor suppressor substrates

The EMBO journal, 2023-08, Vol.42 (16), p.e112414-n/a

2023

Volltextzugriff (PDF)

Biomarker Studies in Early Detection and Prognosis of Breast Cancer

Translational Research in Breast Cancer, 2017, Vol.1026, p.27-39

2017

Volltextzugriff (PDF)

Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer

JAMA network open, 2020-12, Vol.3 (12), p.e2028086-e2028086

2020

Volltextzugriff (PDF)

Discovery of CCL18 antagonist blocking breast cancer metastasis

Clinical & experimental metastasis, 2019-06, Vol.36 (3), p.243-255

2019

Volltextzugriff (PDF)

Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis

Oncotarget, 2016-03, Vol.7 (9), p.10373-10385

2016

Volltextzugriff (PDF)

Circumferential Shaving of the Cavity in Breast-Conserving Surgery: A Randomized Controlled Trial

Annals of surgical oncology, 2019-12, Vol.26 (13), p.4256-4263

2019

Volltextzugriff (PDF)

Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross‐Sectional Survey of 110 Hospitals

The oncologist (Dayton, Ohio), 2020-10, Vol.25 (10), p.e1473-e1480

2020

Volltextzugriff (PDF)

MRI-based radiomic models to predict surgical margin status and infer tumor immune microenvironment in breast cancer patients with breast-conserving surgery: a multicenter validation study

European radiology, 2024-03, Vol.34 (3), p.1774-1789

2024

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

ThemaBreast Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(53)
Buchkapitel
(3)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer

Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer

Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells

Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients

Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy

DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer

Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer

circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death

Targeting Stemness: Implications for Precision Medicine in Breast Cancer

The Role of APAL/ST8SIA6-AS1 lncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells

The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)

LncRNA NRON promotes tumorigenesis by enhancing MDM2 activity toward tumor suppressor substrates

Biomarker Studies in Early Detection and Prognosis of Breast Cancer

Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer

Discovery of CCL18 antagonist blocking breast cancer metastasis

Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis

Circumferential Shaving of the Cavity in Breast-Conserving Surgery: A Randomized Controlled Trial

Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross‐Sectional Survey of 110 Hospitals

MRI-based radiomic models to predict surgical margin status and infer tumor immune microenvironment in breast cancer patients with breast-conserving surgery: a multicenter validation study

Aktive Filter

Suchergebnisse filtern